Your browser doesn't support javascript.
loading
Long-term safety and efficacy results in hepatitis C virus genotype 1-infected patients receiving ombitasvir/paritaprevir/ritonavir + dasabuvir ± ribavirin in the TOPAZ-I and TOPAZ-II trials.
Poordad, Fred; Castro, RuiSarmento E; Asatryan, Armen; Aguilar, Humberto; Cacoub, Patrice; Dieterich, Douglas; Marinho, Rui Tato; Carvalho, Armando; Siddique, Asma; Hu, Yiran Bonnie; Charafeddine, Mariem; Bondin, Mark; Khan, Nader; Cohen, Daniel E; Felizarta, Franco.
Afiliação
  • Poordad F; The Texas Liver Institute, University of Texas Health, San Antonio, TX, USA.
  • Castro RE; Hospital Centre of Porto (Portugal), Biomedical School of Medicine (University of Porto), Porto, Portugal.
  • Asatryan A; AbbVie Inc., North Chicago, IL, USA.
  • Aguilar H; Louisiana Research Center, Shreveport, LA, USA.
  • Cacoub P; Department of Internal Medicine and Clinical Immunology, AP HP, Groupe hospitalier La Pitié-Salpêtrière, Paris, France.
  • Dieterich D; Sorbonne Universités, UPMC Univ, Paris, France.
  • Marinho RT; Mount Sinai School of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Carvalho A; Gastroenterology and Hepatology Department, Centro Hospitalar de Universitário Lisboa Norte and Medical School of Lisbon, University of Lisbon, Lisbon, Portugal.
  • Siddique A; Internal Medicine Department, Hospitais da Universidade de Coimbra (Centro Hospitalar e Universitário de Coimbra), Coimbra, Portugal.
  • Hu YB; Virginia Mason Hospital and Seattle Medical Center, Seattle, WA, USA.
  • Charafeddine M; AbbVie Inc., North Chicago, IL, USA.
  • Bondin M; AbbVie Inc., North Chicago, IL, USA.
  • Khan N; AbbVie Inc., North Chicago, IL, USA.
  • Cohen DE; AbbVie Inc., North Chicago, IL, USA.
  • Felizarta F; AbbVie Inc., North Chicago, IL, USA.
J Viral Hepat ; 27(5): 497-504, 2020 05.
Article em En | MEDLINE | ID: mdl-31954087

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Hepatite C Limite: Humans Idioma: En Revista: J Viral Hepat Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Hepatite C Limite: Humans Idioma: En Revista: J Viral Hepat Ano de publicação: 2020 Tipo de documento: Article